S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7229 −0.32%
CLOSED · 16:05 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead
KN
INSIDER · BBIO · BridgeBio Pharma, Inc. · CHIEF EXECUTIVE OFFICER

Kumar Neil

Every open-market transaction filed under this name, Aug 18 to Aug 19.

Filings
7
0 buys · 7 sells
Bought
open market, at cost
Sold
$3.7M
includes scheduled sales
Buys since
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Aug 19BBIOBridgeBio Pharma, Inc.Chief Executive OfficerSell100$85.65$9K
Aug 19BBIOBridgeBio Pharma, Inc.Chief Executive OfficerSell1,800$84.69$152K
Aug 19BBIOBridgeBio Pharma, Inc.Chief Executive OfficerSell8,100$83.86$679K
Aug 18BBIOBridgeBio Pharma, Inc.Chief Executive OfficerSell1,199$83.77$100K
Aug 18BBIOBridgeBio Pharma, Inc.Chief Executive OfficerSell14,602$82.99$1.2M
Aug 18BBIOBridgeBio Pharma, Inc.Chief Executive OfficerSell17,279$82.21$1.4M
Aug 18BBIOBridgeBio Pharma, Inc.Chief Executive OfficerSell1,900$81.15$154K

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.